Sign inJoin waitlistJoin the waitlist

Rachel Ignacio

Director, UW Positive Research · University of Washington School of Medicine

Credentials: · · · · · ·

History

UW Positive Research · University of Washington School of Medicine
Present
University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Infectious Disease
University of Washington-Seattle Campus
2012–2015
Internal Medicine
Massachusetts General Hospital
2008–2011
University of Washington School of Medicine
2004–2008

Research

Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy
Blood Advances · 2019 · 65 citations
Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
Review · mBio · 2021 · 56 citations
Innovations in Human Immunodeficiency Virus (HIV) Care Delivery During the Coronavirus Disease 2019 (COVID-19) Pandemic: Policies to Strengthen the Ending the Epidemic Initiative-A…
Clinical Infectious Diseases · 2021 · 51 citations

Joseph Eron
14 papers
Judith Currier
12 papers
AJ
Arzhang Javan
11 papers
David Wohl
10 papers
ED
Eric Daar
10 papers
Kara Chew
10 papers
Jonathan Li
9 papers
Adrienne Shapiro
8 papers
Alex Greninger
7 papers
Kenneth Mayer
6 papers
Mari Kitahata
6 papers
Michael Boeckh
6 papers

Grants

Seattle Clinical Trials Unit
National Institute of Allergy and Infectious Diseases · UM1
PI · $1.6M · Fred Hutchinson Cancer Center
2007–2027
"NextGen Long-Acting Platform: Targeted Combination Antiretrovirals"
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $1 · University of Washington
2019–2024
Addressing the Burden of Untreated HIV in Cancer Patients in Sub-Saharan Africa: Feasibility and Planning for a Pragmatic Clinical Trial
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $330.3K · University of Washington
2021–2024
Determining the Component Causes of Systemic Immune Activation That Moderate HIV Acquisition and Establishment of the Latent Viral Reservoir
National Institute of Allergy and Infectious Diseases · K23
Contact PI · $868.3K · University of Washington
2017–2022

Clinical trials

First in Human Study of TLC-ART 101 (ACTU 2001)
Principal investigator · Completed · Phase 1
University of Washington
2023–2024
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Site PI · Recruiting · Phase 2
ViiV Healthcare
2026–2028